Â鶹´«Ã½

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

In the last 7 days
GlobeNewswire (Press Release)07:46 31-Oct-24
Drug Discovery & Development01:50 31-Oct-24
PR Newswire (Press Release)07:05 29-Oct-24
In the last month
NBC Connecticut17:27 25-Oct-24
Zacks11:36 25-Oct-24
The New Times06:29 24-Oct-24
Annenberg Political Fact Check18:14 22-Oct-24
Scrip Pharma Intelligence13:49 22-Oct-24
Scrip Pharma Intelligence13:49 22-Oct-24
Scrip Pharma Intelligence12:32 21-Oct-24
Seeking Alpha11:25 21-Oct-24
Clinical Trials Arena09:25 21-Oct-24
GlobeNewswire (Press Release)06:47 21-Oct-24
Simply Wall St16:11 18-Oct-24
FierceBiotech13:05 18-Oct-24
Barchart12:54 18-Oct-24
ENDPOINTS11:28 18-Oct-24
TipRanks09:37 18-Oct-24
Scrip Pharma Intelligence01:32 16-Oct-24
Scrip Pharma Intelligence01:32 16-Oct-24
Yahoo! US12:56 12-Oct-24
TechCrunch12:09 12-Oct-24
Thomson Reuters - Practical Law08:34 8-Oct-24
GOV.UK (Press Release)08:12 8-Oct-24
DD News06:15 8-Oct-24
Singularity Hub10:01 7-Oct-24
Louisville Public Media12:05 6-Oct-24
HumanProgress14:22 4-Oct-24
ENDPOINTS15:53 2-Oct-24
view more headlines
31 Oct 07:46

About our BioNTech news

Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.